ngs

CRISPR-Cas9 presents new possibilities for Thalassemia treatment.

The autosomal recessive inherited blood disorder, b-thalassemia, is caused by reduced or absent synthesis of the beta chains of hemoglobin due to mutations within the HBB gene. The severity of the disease depends on the nature of the mutation and whether the mutations are present in heterozygous or homozygous form. Another autosomal recessive inherited hemoglobinopathy …

CRISPR-Cas9 presents new possibilities for Thalassemia treatment. Read More »

Familial Hypercholesterolemia Awareness Day 2018

Familial Hypercholesterolemia (FH) is an hereditary disease which, despite being treatable, is vastly underdiagnosed. Individuals with FH have a reduced ability to remove LDL-cholesterol from the blood, and an increased risk of heart disease, stroke, and potentially fatal cardiac events. September 24th is FH Awareness Day, where the aim is to raise awareness and understanding …

Familial Hypercholesterolemia Awareness Day 2018 Read More »